Changes in Serum Myostatin Levels in Alcoholic Hepatitis Correlate with Improvement in MELD
- PDF / 2,012,628 Bytes
- 12 Pages / 595.276 x 790.866 pts Page_size
- 59 Downloads / 204 Views
ORIGINAL ARTICLE
Changes in Serum Myostatin Levels in Alcoholic Hepatitis Correlate with Improvement in MELD Hani Shamseddeen1 · Abhishek Madathanapalli2 · Vijay S. Are1 · Vijay H. Shah3 · Arun J. Sanyal4 · Qing Tang5 · Tiebing Liang1 · Kayla Gelow1 · Teresa A. Zimmers6 · Naga Chalasani1 · Archita P. Desai1 Received: 13 July 2020 / Accepted: 20 September 2020 © Springer Science+Business Media, LLC, part of Springer Nature 2020
Abstract Background Alcoholic hepatitis (AH) is a serious clinical syndrome often associated with muscle wasting. Myostatin, a member of the transforming growth factor-β superfamily, has been studied in diseases with muscle wasting; however, the role of myostatin in AH is unknown. Aims To investigate the association between myostatin, clinical variables, and outcomes in AH. Methods We analyzed data for cases of AH and controls of heavy drinkers (HD) in TREAT001 (NCT02172898) with serum myostatin levels (AH: n = 131, HD: n = 124). We compared characteristics between the two groups at baseline, 30, and 90 days and explored correlations between myostatin and clinical variables. We then modeled the relationship of myostatin to other variables, including mortality. Results Baseline median myostatin was lower in AH compared to HD (males: 1.58 vs 3.06 ng/ml, p
Data Loading...
